These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 1669605)

  • 1. [Immunologic and clinical definition of the rejection reaction in kidney transplantation].
    Durinović-Bello I; Puretić Z; Turk R; Bubić-Filipi L; Pasini J; Thune S; Barisić D; Milavec-Puretić V; Kastelan A
    Lijec Vjesn; 1991; 113(11-12):386-90. PubMed ID: 1669605
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Minimization of immunosuppressive therapy and immunological monitoring of kidney transplant recipients with long-term allograft survival.
    Pretagostini R; Cinti P; Lai Q; Poli L; Berloco PB
    Transpl Immunol; 2008 Nov; 20(1-2):3-5. PubMed ID: 18773959
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunological diagnosis of rejection in human renal allotransplanted patients--a prospective study.
    Kristensen T; Grunnet N; Hansen HE; Fjeldborg O; Olsen TS; Kissmeyer-Nielsen F
    Proc Eur Dial Transplant Assoc; 1977; 14():313-20. PubMed ID: 341132
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-glutathione S-transferase T1 antibody-mediated rejection in C4d-positive renal allograft recipients.
    Aguilera I; Alvarez-Marquez A; Gentil MA; Fernandez-Alonso J; Fijo J; Saez C; Wichmann I; Nuñez-Roldan A
    Nephrol Dial Transplant; 2008 Jul; 23(7):2393-8. PubMed ID: 18308775
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of cytotoxic antibodies following renal allograft transplantation is associated with reduced graft survival due to chronic vascular rejection.
    Davenport A; Younie ME; Parsons JE; Klouda PT
    Nephrol Dial Transplant; 1994; 9(9):1315-9. PubMed ID: 7816298
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute and hyperacute humoral rejection in kidney allograft recipients treated with anti-human thymocyte antibodies.
    Colovai AI; Vasilescu ER; Foca-Rodi A; Kim-Schulze S; Hussaini N; D'agati VD; Markowitz GS; Wang C; Cohen DJ; Hardy MA; Suciu-Foca N
    Hum Immunol; 2005 May; 66(5):501-12. PubMed ID: 15935887
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pretransplant detection of anti-endothelial cell antibodies could predict renal allograft outcome.
    Ismail AM; Badawi RM; El-Agroudy AE; Mansour MA
    Exp Clin Transplant; 2009 Jun; 7(2):104-9. PubMed ID: 19715514
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical and anti-HLA antibody profile of nine renal transplant recipients with failed grafts: donor-specific and non-donor-specific antibody development.
    Rebellato LM; Ozawa M; Verbanac KM; Catrou P; Haisch CE; Terasaki PI
    Clin Transpl; 2006; ():241-53. PubMed ID: 18365382
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Living donor kidney transplantation across positive crossmatch: the University of Illinois at Chicago experience.
    Thielke JJ; West-Thielke PM; Herren HL; Bareato U; Ommert T; Vidanovic V; Campbell-Lee SA; Tzvetanov IG; Sankary HN; Kaplan B; Benedetti E; Oberholzer J
    Transplantation; 2009 Jan; 87(2):268-73. PubMed ID: 19155983
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The use of tests for cell mediated cytotoxicity in clinical kidney transplantation.
    Dickmeiss E
    Scand J Urol Nephrol Suppl; 1977; (42):51-4. PubMed ID: 356222
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Renal transplantation in patients with positive lymphocytotoxicity crossmatches: one center's experience.
    Magee CC; Felgueiras J; Tinckam K; Malek S; Mah H; Tullius S
    Transplantation; 2008 Jul; 86(1):96-103. PubMed ID: 18622284
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monitoring and modulation of recipient immune responsiveness to prevent kidney graft rejection in the early post-transplant period.
    Renna E; Sansonetti P; Nesci C; Famulari A; Cortesini R
    Proc Eur Dial Transplant Assoc; 1977; 14():336-41. PubMed ID: 341135
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Failure of anti-CD20 monoclonal antibody therapy to prevent antibody-mediated rejection in three crossmatch-positive renal transplant recipients.
    Matignon M; Tagnaouti M; Audard V; Dahan K; Lang P; Grimbert P
    Transplant Proc; 2007 Oct; 39(8):2565-7. PubMed ID: 17954175
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Frequency and clinical implications of development of donor-specific and non-donor-specific HLA antibodies after kidney transplantation.
    Hourmant M; Cesbron-Gautier A; Terasaki PI; Mizutani K; Moreau A; Meurette A; Dantal J; Giral M; Blancho G; Cantarovich D; Karam G; Follea G; Soulillou JP; Bignon JD
    J Am Soc Nephrol; 2005 Sep; 16(9):2804-12. PubMed ID: 16014742
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peritubular capillary C4d staining in late acute renal allograft rejection--is it relevant?
    Satoskar AA; Lehman AM; Nadasdy GM; Sedmak DD; Pesavento TE; Henry ML; Pelletier RP; Ferguson RM; Nadasdy T
    Clin Transplant; 2008; 22(1):61-7. PubMed ID: 18217907
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Excellent renal allograft survival in donor-specific antibody positive transplant patients-role of intravenous immunoglobulin and rabbit antithymocyte globulin.
    Mai ML; Ahsan N; Wadei HM; Genco PV; Geiger XJ; Willingham DL; Taner CB; Hewitt WR; Grewal HP; Nguyen JH; Hughes CB; Gonwa TA
    Transplantation; 2009 Jan; 87(2):227-32. PubMed ID: 19155977
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IgG donor-specific crossmatches are not associated with graft rejection or poor graft survival after liver transplantation. An assessment by cytotoxicity and flow cytometry.
    Donaldson PT; Thomson LJ; Heads A; Underhill JA; Vaughan RW; Rolando N; Williams R
    Transplantation; 1995 Nov; 60(9):1016-23. PubMed ID: 7491675
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reappraisal of HLA antibody analysis and crossmatching in kidney transplantation.
    Lee PC; Ozawa M
    Clin Transpl; 2007; ():219-26. PubMed ID: 18642453
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Absence of irreversible rejection in the presence of warm anti-donor-HLA class I cytotoxic IgG antibody.
    Shoker A; Klassen J; Herbut B
    Clin Nephrol; 1997 Feb; 47(2):87-91. PubMed ID: 9049455
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Value of donor-specific antibody detection in first-graft renal transplant recipients with a negative complement-dependent cytotoxic crossmatch.
    Mahmoud KM; Ismail AM; Sheashaa HA; Gheith OA; Kamal MM; Ghoneim MA
    Exp Clin Transplant; 2009 Jun; 7(2):124-8. PubMed ID: 19715518
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.